AMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3-BETA INHIBITORS

(19)

(11)

EP 1 442 019 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	30.10.2013 Bulletin 2013/44

(45)	Mention of the grant of the patent:
	10.10.2007 Bulletin 2007/41

(21)	Application number: 02790304.6

(22)	Date of filing: 29.10.2002

(51)

International Patent Classification (IPC):

C07D 213/82^(2006.01)
C07D 413/12^(2006.01)
C07D 407/12^(2006.01)
C07D 401/12^(2006.01)
A61K 31/505^(2006.01)
A61P 25/28^(2006.01)

C07D 239/42^(2006.01)
C07D 413/14^(2006.01)
C07D 417/12^(2006.01)
C07D 403/12^(2006.01)
A61P 3/10^(2006.01)

(86)	International application number:
	PCT/EP2002/012067

(87)	International publication number:
	WO 2003/037869 (08.05.2003 Gazette 2003/19)

(54)	AMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3-BETA INHIBITORS AMIDDERIVATE ALS INHIBITOREN DER GLYCOGENSYNTHASEKINASE-3-BETA DERIVES AMIDES UTILISES EN TANT QU'INHIBITEURS DE LA GLYCOGENE SYNTHASE KINASE 3-BETA

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

01.11.2001 EP 01204193

(43)	Date of publication of application:
	04.08.2004 Bulletin 2004/32

(73)	Proprietor: Janssen Pharmaceutica NV
	2340 Beerse (BE)

(72)

Inventors:

FREYNE, Eddy Jean Edgard
2340 Beerse (BE)
BUIJNSTERS, Peter Jacobus Johannes Antonius
2340 Beerse (BE)
WILLEMS, Marc
2340 Beerse (BE)
EMBRECHTS, Werner Constant Johan
2340 Beerse (BE)
LACRAMPE, Jean Fernand Armand, Janssen-Cilag
92787 Issy-les-Moulineaux (FR)
JANSSEN, Paul Adriaan Jan (deceased)
(BE)
LEWI, Paulus Joannes
2340 Beerse (BE)
HEERES, Jan
2340 Beerse (BE)
DE JONGE, Marc René
2264 BH Leidschendam (NL)
KOYMANS, Lucien Maria Henricus
2340 Beerse (BE)
DAEYAERT, Frederik Frans Desire
2340 Beerse (BE)
KUKLA, Michael Joseph
Maple Glen, PA 19002 (US)
GEERTS, Hugo, Alfons, Gabriel
Berwyn, PA 19312 (US)
NUYDENS, Rony Maria
2340 Beerse (BE)
MERCKEN, Marc Hubert
2340 Beerse (BE)
LUDOVICI, Donald William, Janssen Pharmac. Inc.
Titusville, NJ 08560 (US)
JANSSEN, Paul, Peter, Maria
B-9052 Zwijnaarde (BE)
JANSSEN, Graziella, Maria, Constantina
B-2300 Turnhout (BE)
JANSSEN, Jasmin, Josee, Werner
2360 Aartselaar (BE)
JANSSEN, Maroussia, Godelieve, Frank
B- 1410 Waterloo (BE)
JANSSEN, Herwig, Josephus, Margareta
B-2970 Schide (BE)
ARTS, Theodora, Joanna, Francisca
B-2350 Vosselaar (BE)

(56)

References cited: :

EP-A- 1 054 004
WO-A-99/65897
GB-A- 1 198 551
US-A- 5 264 437

WO-A-97/19065
FR-A- 2 248 842
GB-A- 1 401 549
US-A- 6 022 884

OSSELAERE ET AL: "anti-inflammatory 2-anilinonicotinamides" FARMACEUTISCH TIJDSCHRIFT VOOR BELGIE, ZOERSEL, BE, vol. 50, no. 4, 1973, pages 338-344, XP002129423 ISSN: 0771-2367
SPANO R., LINARI G., MARRI R.: BOLLETTINO CHIMICO FARMACEUTICO, vol. 109, no. 8, 1970, pages 485-489, XP002186934

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).